Trials / Unknown
UnknownNCT03418155
Efficacy and Safety of TongBi Capsule in Patients With Knee Osteoarthritis
Efficacy and Safety of TongBi Capsule in Patients With Knee Osteoarthritis:a Randomized, Double-blind, Placebo-controlled Post - Market Clinical Study
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the efficacy and safety of TongBi capsule compared with placebo in the treatment of knee osteoarthritis in adults.Half of participants will receive TongBi capsule in combination,while the other half will receive a Placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Treatment of TongBi Capsule | TongBi Capsule:0.31g,3times a day, oral, for 4 weeks. |
| DRUG | Treatment of TongBi placebo | TongBi placebo:0.31g,3times a day, oral, for 4 weeks. |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2019-04-01
- Completion
- 2019-10-01
- First posted
- 2018-02-01
- Last updated
- 2018-02-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03418155. Inclusion in this directory is not an endorsement.